Paragonix Announces Transplanted-Cost Savings & Clinical Results for Donor Heart Preservation using SherpaPak Cardiac Transport System in Routine & Complex Heart Transplantation

  • Post author:
  • Post category:News

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Paragonix Technologies, Inc. today announced clinical results presented during the Paragonix SherpaPak™ CTS 2019 International Heart Summit held during the International Society for Heart and Lung Transplantation (ISHLT) 2019 Annual Meeting in Orlando, FL. Five U.S. and European Centers shared clinical use experiences of the Paragonix SherpaPak™ Cardiac Transport System (CTS) for the preservation of donor hearts destined for heart transplantation.

Continue ReadingParagonix Announces Transplanted-Cost Savings & Clinical Results for Donor Heart Preservation using SherpaPak Cardiac Transport System in Routine & Complex Heart Transplantation

Paragonix & the Lung Transplant Foundation Announce Expansion of Partnership to Accelerate Commercialization of Innovative Lung Preservation Technologies

  • Post author:
  • Post category:News

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Paragonix Technologies Inc., and the Lung Transplant Foundation (LTF) today announced an expansion of their partnership for the development of a series of innovative technologies for improved donor lung preservation.At a…

Continue ReadingParagonix & the Lung Transplant Foundation Announce Expansion of Partnership to Accelerate Commercialization of Innovative Lung Preservation Technologies

Paragonix Initiates Global Post Market Registry Evaluating Clinical Outcomes in Patients who Receive Donor Hearts Transported with Paragonix SherpaPak™ Cardiac Transport System

  • Post author:
  • Post category:News

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Paragonix Technologies, Inc. today announced the opening of the Global Utilization And Registry Database for Improved heArt preservatioN (“GUARDIAN”) post-market registry, which will assess clinical outcomes when employing the Paragonix…

Continue ReadingParagonix Initiates Global Post Market Registry Evaluating Clinical Outcomes in Patients who Receive Donor Hearts Transported with Paragonix SherpaPak™ Cardiac Transport System

Utilization of New Heart Preservation Technology in the Era of New Organ Allocation and Extended Ischemic Times

Funamoto, et al.Journal of Heart and Lung TransplantationApril 2019; Volume 38, Issue 4, S44.https://doi.org/10.1016/j.healun.2020.01.1046Purpose : Current ice bag heart preservation technique is associated with wide fluctuations of organ temperature, resulting in…

Continue ReadingUtilization of New Heart Preservation Technology in the Era of New Organ Allocation and Extended Ischemic Times